• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卒中带溶栓后出血性转化(HT)及症状性脑出血(sICH)风险预测模型

Hemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt.

作者信息

Siegler James E, Alvi Muhammad, Boehme Amelia K, Lyerly Michael J, Albright Karen C, Shahripour Reza Bavarsad, Rawal Pawan V, Kapoor Niren, Sisson April, Houston J Thomas, Alexandrov Anne W, Martin-Schild Sheryl, Alexandrov Andrei V

机构信息

Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Stroke Program, Department of Neurology, School of Medicine, University of Alabama at Birmingham, RWUH 226M, 1720 2nd Avenue S, Birmingham, AL 35249, USA.

出版信息

ISRN Stroke. 2013;2013:681673. doi: 10.1155/2013/681673.

DOI:10.1155/2013/681673
PMID:24504047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3912845/
Abstract

BACKGROUND

Symptomatic intracerebral hemorrhage (sICH) remains the most feared complication of intravenous tissue plasminogen activator (IV tPA) treatment. We aimed to investigate how previously validated scoring methodologies would perform in treated patients in two US Stroke Belt states.

METHODS AND RESULTS

We retrospectively reviewed consecutive patients from two centers in two Stroke Belt states who received IV tPA (2008-2011). We assessed the ability of three models to predict sICH. sICH was defined as a type 2 parenchymal hemorrhage with deterioration in National Institutes of Health Stroke Scale (NIHSS) score of ≥4 points or death. Among 457 IV tPA-treated patients, 19 (4.2%) had sICH (mean age 68, 26.3% Black, 63.2% female). The Cucchiara model was most predictive of sICH in the entire cohort (AUC: 0.6528) and most predictive of sICH among Blacks (OR = 6.03, 95% CI 1.07-34.1, = 0.0422) when patients were dichotomized by score.

CONCLUSIONS

In our small sample from the racially heterogeneous US Stroke Belt, the Cucchiara model outperformed the other models at predicting sICH. While predictive models should not be used to justify nontreatment with thrombolytics, those interested in understanding contributors to sICH may choose to use the Cucchiara model until a Stroke Belt model is developed for this region.

摘要

背景

有症状性脑出血(sICH)仍然是静脉注射组织型纤溶酶原激活剂(IV tPA)治疗最令人担忧的并发症。我们旨在研究先前经过验证的评分方法在两个美国中风带州接受治疗的患者中的表现。

方法与结果

我们回顾性分析了来自两个中风带州的两个中心在2008 - 2011年期间接受IV tPA治疗的连续患者。我们评估了三种模型预测sICH的能力。sICH被定义为2型脑实质出血,美国国立卫生研究院卒中量表(NIHSS)评分恶化≥4分或死亡。在457例接受IV tPA治疗的患者中,19例(4.2%)发生了sICH(平均年龄68岁,26.3%为黑人,63.2%为女性)。在整个队列中,Cucchiara模型对sICH的预测性最强(AUC:0.6528),当按评分将患者二分法分类时,在黑人中对sICH的预测性也最强(OR = 6.03,95% CI 1.07 - 34.1,P = 0.0422)。

结论

在我们来自种族异质的美国中风带的小样本中,Cucchiara模型在预测sICH方面优于其他模型。虽然预测模型不应被用于证明不进行溶栓治疗的合理性,但那些有兴趣了解sICH相关因素的人在为本地区开发出中风带模型之前,可能会选择使用Cucchiara模型。

相似文献

1
Hemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt.卒中带溶栓后出血性转化(HT)及症状性脑出血(sICH)风险预测模型
ISRN Stroke. 2013;2013:681673. doi: 10.1155/2013/681673.
2
Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.症状性颅内出血后静脉溶栓治疗:预测因素和预测模型的验证。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104360. doi: 10.1016/j.jstrokecerebrovasdis.2019.104360. Epub 2019 Sep 14.
3
Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.比较静脉溶栓治疗后预测症状性脑出血的风险评分系统。
Stroke. 2013 Jun;44(6):1561-6. doi: 10.1161/STROKEAHA.111.000651. Epub 2013 Apr 30.
4
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.预测静脉注射阿替普酶治疗的缺血性脑卒中发生症状性颅内出血的风险:安全实施卒中治疗(SITS)症状性颅内出血风险评分。
Stroke. 2012 Jun;43(6):1524-31. doi: 10.1161/STROKEAHA.111.644815. Epub 2012 Mar 22.
5
Cerebral microbleeds shouldn't dictate treatment of acute stroke: a retrospective cohort study evaluating risk of intracerebral hemorrhage.脑微出血不应决定急性卒中的治疗:一项评估脑出血风险的回顾性队列研究
BMC Neurol. 2018 Mar 27;18(1):33. doi: 10.1186/s12883-018-1029-0.
6
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.基于 STARTING-SICH 量表的静脉溶栓后症状性脑出血预测模型
Stroke. 2018 Feb;49(2):397-404. doi: 10.1161/STROKEAHA.117.018427. Epub 2018 Jan 8.
7
Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy.静脉注射组织型纤溶酶原激活剂治疗是颈动脉内膜切除术后症状性脑出血的独立危险因素。
Neurosurgery. 2014 Mar;74(3):254-61. doi: 10.1227/NEU.0000000000000261.
8
Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).血清肌酐可能提示静脉注射组织型纤溶酶原激活剂(IV tPA)后出现症状性颅内出血的风险。
Medicine (Baltimore). 2013 Nov;92(6):317-323. doi: 10.1097/MD.0000000000000006.
9
Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.基于颅内出血风险或功能预后不良对急性缺血性卒中患者使用重组组织型纤溶酶原激活剂进行靶向治疗:第三次国际卒中试验分析
Stroke. 2014 Apr;45(4):1000-6. doi: 10.1161/STROKEAHA.113.004362. Epub 2014 Mar 6.
10
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.静脉注射重组组织型纤溶酶原激活剂(IV rt-PA)后出现的症状性脑出血及再通:一项多中心研究
Neurology. 2008 Oct 21;71(17):1304-12. doi: 10.1212/01.wnl.0000313936.15842.0d. Epub 2008 Aug 27.

引用本文的文献

1
GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.GSK-3β抑制剂TWS119可减轻大鼠急性缺血性卒中后rtPA诱导的出血性转化并激活Wnt/β-连环蛋白信号通路。
Mol Neurobiol. 2016 Dec;53(10):7028-7036. doi: 10.1007/s12035-015-9607-2. Epub 2015 Dec 15.

本文引用的文献

1
ICD9 codes cannot reliably identify hemorrhagic transformation of ischemic stroke.国际疾病分类第九版(ICD9)编码无法可靠地识别缺血性卒中的出血性转化。
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):505-6. doi: 10.1161/CIRCOUTCOMES.113.000215. Epub 2013 Jul 2.
2
Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis.比较静脉溶栓治疗后预测症状性脑出血的风险评分系统。
Stroke. 2013 Jun;44(6):1561-6. doi: 10.1161/STROKEAHA.111.000651. Epub 2013 Apr 30.
3
Ethnic disparities trump other risk factors in determining delay to emergency department arrival in acute ischemic stroke.
种族差异在确定急性缺血性脑卒中患者延迟到急诊科就诊的时间方面比其他风险因素更为重要。
Ethn Dis. 2013 Winter;23(1):29-34.
4
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100.使用年龄和 NIH 卒中量表预测卒中预后:SPAN-100。
Neurology. 2013 Jan 1;80(1):21-8. doi: 10.1212/WNL.0b013e31827b1ace. Epub 2012 Nov 21.
5
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.症状性颅内出血:急性缺血性脑卒中静脉溶栓治疗后之关键回顾。
Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1.
6
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.预测静脉注射阿替普酶治疗的缺血性脑卒中发生症状性颅内出血的风险:安全实施卒中治疗(SITS)症状性颅内出血风险评分。
Stroke. 2012 Jun;43(6):1524-31. doi: 10.1161/STROKEAHA.111.644815. Epub 2012 Mar 22.
7
Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.预测接受 IV 溶栓治疗的缺血性脑卒中患者结局:DRAGON 评分。
Neurology. 2012 Feb 7;78(6):427-32. doi: 10.1212/WNL.0b013e318245d2a9.
8
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.iScore 预测急性缺血性脑卒中溶栓治疗的效果。
Stroke. 2012 May;43(5):1315-22. doi: 10.1161/STROKEAHA.111.646265. Epub 2012 Feb 3.
9
The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke.血清铁蛋白水平是急性缺血性脑卒中出血转化的重要预测指标。
Eur J Neurol. 2012 Apr;19(4):570-7. doi: 10.1111/j.1468-1331.2011.03564.x. Epub 2011 Oct 15.
10
Disparities in stroke incidence contributing to disparities in stroke mortality.导致卒中死亡率差异的卒中发病率差异。
Ann Neurol. 2011 Apr;69(4):619-27. doi: 10.1002/ana.22385. Epub 2011 Mar 17.